Elotuzumab Active Not Recruiting Phase 3 Trials for Multiple Myeloma (MM) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Active Not Recruiting | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03651128 | Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) |